Judges Scientific warns on year ahead
Shares in Judges Scientific, the Sussex based manufacturer of scientific instruments, fell despite the company saying it expects adjusted earnings per share for 2011 to be ahead of the consensus forecast.
Shares in Judges Scientific, the Sussex based manufacturer of scientific instruments, fell despite the company saying it expects adjusted earnings per share for 2011 to be ahead of the consensus forecast.
Investors were evidently concerned over the firm's warning that the year ahead remains uncertain.
"Operations were satisfactory throughout the year and good progress was recorded in sales, profitability and cash conversion," the firm said.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"The global economic outlook remains difficult and the year ahead promises much uncertainty. Thankfully our sector has remained relatively sheltered from the general despondency, particularly in the Far East, which accounts for a significant proportion of our sales.
"With a solid order book, a strong balance sheet and a number of new or updated products, the directors are confident that the group is well equipped for 2012."
The share price fell 1.76% to 417.5p by 13:08.
NR
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published